Topic
Psychotropic drug
About: Psychotropic drug is a research topic. Over the lifetime, 2309 publications have been published within this topic receiving 54070 citations.
Papers published on a yearly basis
Papers
More filters
Journal Article•
TL;DR: The use of sulpirid in psychiatry allows to delineate three types of activity of this compound which originality consists most in this triple association: neuroleptic activity, anticonfusional and antidepressive as discussed by the authors.
Abstract: The use of sulpirid in psychiatry allows to delineate three types of activity of this compound which originality consists most in this triple association: neuroleptic activity, as well as anticonfusional and antidepressive. The psychodynamic and phenomenological evaluation of patients receiving a sulpirid treatment, has led us to consider the process of "psychic decompensation" as a target variable particularly sensitive to the action of this psychotropic drug. This process can be found in various pathological states--acute delirious states, depressive episodes, anxiety, autism, stress situation--where sulpirid acts, beside its specific thymoanaleptic or neuroleptic properties, through a "aspecific recompensation activity". This translates, psychopathologically, the action of sulpirid on the vegetative brain as well as the anti-stress properties of this psychrotropic drug, as verified in animal experiment.
2 citations
TL;DR: The overall prescription rate of psychotropic drugs in a Nigerian teaching hospital was 33.1%.
Abstract: The overall prescription rate of psychotropic drugs in a Nigerian teaching hospital was 33.1%. This was slightly higher among surgical than medical patients. It is suggested that more attention needs to be paid to psychotropic drug education in developing countries in order to ensure a more rational use of these drugs.
2 citations
TL;DR: The sympathomimetic, antidepressant, anticonvulsant, histamine-modulating, antidiabetic, and gastrointestinal drugs that have been found to cause weight loss and might be considered for adjunctive use in the overall management of psychotropic drug-related weight gain are described.
Abstract: Weight gain is a significant problem for many patients taking various psychotropic medications. The U.S. Food and Drug Administration (FDA) has approved certain medications for the treatment of obesity. Other medications known to be associated with weight loss could be used for treating obesity, although they are not FDA approved for this indication. This article briefly describes the sympathomimetic, antidepressant, anticonvulsant, histamine-modulating, antidiabetic, and gastrointestinal drugs that have been found to cause weight loss and might be considered for adjunctive use in the overall management of psychotropic drug-related weight gain. However, even if such drugs are effective, all patients should receive ongoing dietary and physical activity counseling.
2 citations
TL;DR: A series of cases which first led to a moral responsibility toward the fetus/neonate, then to abortive psychiatric court intervention, and finally to the successful intervention of the juvenile court are presented.
2 citations
01 Jan 1986
TL;DR: Through consideration of nonreceptor mediated interaction, the authors can more fully appreciate the potentiation that occurs between seemingly unrelated substances and the ability or lack of the ability to medically treat such interactions specifically.
Abstract: Whereas the effects of individual psychotropic drugs depend upon drug type, route of administration, dose, and frequency of use, as well as unique subject (patient) variables, the actions achieved by two or more psychotropics taken concurrently are complicated by their influence upon each other. Interactions may be antagonistic, additive, or synergistic and are frequently predictable, given a basic understanding of the kinetic and dynamic characteristics for each drug. This knowledge should enable rational interpretation, therapeutic intervention, and possible prevention of polydrug toxicity.
2 citations